Synthesis, spectral analysis and pharmacological study of N’-substituted-2-(5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazides

A series of molecules bearing multiple functional groups were synthesized to study their antibiotic effect against Gram-positive and Gram-negative bacteria and lipoxygenase activity as well. 2,4-Dimethylcarbolic acid (1) was refluxed with ethyl 2-bromoacetate to synthesize ethyl 2-(2,4-dimethylpheno...

Full description

Bibliographic Details
Main Authors: Abbasi, M.A (Author), Aziz-ur-Rehman (Author), Rasool, S. (Author), Shah, S.A.A (Author), Siddiqui, S.Z (Author)
Format: Article
Language:English
Published: Faculdade de Ciencias Farmaceuticas (Biblioteca) 2016
Subjects:
Online Access:View Fulltext in Publisher
View in Scopus
LEADER 05210nam a2200781Ia 4500
001 10.1590-s1984-82502016000300013
008 220120s2016 CNT 000 0 und d
020 |a 19848250 (ISSN) 
245 1 0 |a Synthesis, spectral analysis and pharmacological study of N’-substituted-2-(5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazides 
260 0 |b Faculdade de Ciencias Farmaceuticas (Biblioteca)  |c 2016 
520 3 |a A series of molecules bearing multiple functional groups were synthesized to study their antibiotic effect against Gram-positive and Gram-negative bacteria and lipoxygenase activity as well. 2,4-Dimethylcarbolic acid (1) was refluxed with ethyl 2-bromoacetate to synthesize ethyl 2-(2,4-dimethylphenoxy)acetate (2). Compound 2 was converted to the corresponding hydrazide 3, again on refluxing with hydrazine. The compound 5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-thiol (4) was synthesized by the reaction of 3 and CS2 in the presence of KOH. Compound 4 was further converted to the corresponding ester 5 and then 2-(5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazide (6). The final molecules N’-substituted-2-(5-((2,4-dimethylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)acetohydrazide, 8a-m, bearing ether, 1,3,4-oxadiazole, thioether, hydrazone and azomethine functional groups were synthesized by stirring the aryl carboxaldehydes 7a-m with 6 in methanol at room temperature. The depicted structures of all synthesized molecules were corroborated by IR, 1H-NMR and EIMS spectral data analysis. 8m and 8i showed substantial antibacterial activity and lipoxygenase inhibitory activity, respectively. © 2016, Faculdade de Ciencias Farmaceuticas (Biblioteca). All rights reserved. 
650 0 4 |a 1,3,4 oxadiazole derivative 
650 0 4 |a 2,4 dimethylcarbolic acid 
650 0 4 |a 5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 thiol 
650 0 4 |a acetic acid 
650 0 4 |a Acetohydrazides/antibacterial activity/acetohydrazides/lipoxygenase/inhibition activity 
650 0 4 |a Acetohydrazides/synthesis 
650 0 4 |a antibacterial activity 
650 0 4 |a Article 
650 0 4 |a azomethine ylide 
650 0 4 |a Bacillus subtilis 
650 0 4 |a baicalein 
650 0 4 |a controlled study 
650 0 4 |a drug structure 
650 0 4 |a drug synthesis 
650 0 4 |a enzyme inhibition 
650 0 4 |a Escherichia coli 
650 0 4 |a ether 
650 0 4 |a ethyl 2 (2,4 dimethylphenoxy)acetate 
650 0 4 |a ethyl 2 bromoacetate 
650 0 4 |a hydrazide 
650 0 4 |a hydrazone derivative 
650 0 4 |a infrared spectroscopy 
650 0 4 |a lipoxygenase 
650 0 4 |a mass spectrometry 
650 0 4 |a methanol 
650 0 4 |a minimum inhibitory concentration 
650 0 4 |a n' (2 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (2 methylbenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (2 nitrobenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (3 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (3 methylbenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (3 nitrobenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (4 hydroxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (4 methoxybenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (4 methylbenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' (4 nitrobenzylidene) 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' [4 (diethylamino)benzylidene] 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' [4 (dimethylamino)benzylidene] 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a n' 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide derivative 
650 0 4 |a n' benzylidene 2 [5 [(2,4 dimethylphenoxy)methyl] 1,3,4 oxadiazol 2 ylthio]acetohydrazide 
650 0 4 |a nonhuman 
650 0 4 |a phenol 
650 0 4 |a proton nuclear magnetic resonance 
650 0 4 |a Pseudomonas aeruginosa 
650 0 4 |a room temperature 
650 0 4 |a Salmonella enterica serovar Typhi 
650 0 4 |a Staphylococcus aureus 
650 0 4 |a thiol 
650 0 4 |a unclassified drug 
700 1 0 |a Abbasi, M.A.  |e author 
700 1 0 |a Aziz-ur-Rehman  |e author 
700 1 0 |a Rasool, S.  |e author 
700 1 0 |a Shah, S.A.A.  |e author 
700 1 0 |a Siddiqui, S.Z.  |e author 
773 |t Brazilian Journal of Pharmaceutical Sciences  |x 19848250 (ISSN)  |g 52 3, 471-482 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1590/s1984-82502016000300013 
856 |z View in Scopus  |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006043172&doi=10.1590%2fs1984-82502016000300013&partnerID=40&md5=601a74d0191422325549fcfb7892de56